Daiwa Pharmaceutical Co., Ltd. (Head Office: Setagaya-ku, Tokyo, President: Yasuo Ninomiya) started marketing "NKCP," a nattokinase-containing food on November 15.
"NKCP"
Regular Retail Price \6,800 (90 capsules) ("NKCP powder" is available for OEM and can also be supplied in bulk.) Having long studied the physiological advantages of traditional Japanese foods to develop safe and beneficial functional food, Daiwa Pharmaceutical Co., Ltd. was quick to pay attention to nattokinase contained in natto and has been working on a research project in collaboration with Kurashiki University of Science and the Arts (Prof. Hiroyuki Sumi) and Chiba University. As a result, we have succeeded in manufacturing a powder formulation with stable high activity while removing natto's distinctive taste and odor, which is an innovation, and have now launched the product.
The physiological activity of nattokinase, etc. has already been published in various fields. Daiwa Pharmaceutical Co., Ltd.'s "NKCP powder" became popular before the launch and was featured in a special report, "The thrombolytic activity of natto (nattokinase)," in the following TV programs.

0Nippon Television Network (NTV) News Plus One (June 29)
0Fuji Television Hakkutsu! Aru Aru Daijiten (in Japanese) (September 23)


"NKCP" has the following characteristics.
0Its activity is stable at room temperature due to the high concentration of nattokinase units.
0The nattokinase activity of NKCP is constant.
0It is free from natto's distinctive odor and viscid texture.
0There is little effect on other drugs as it does not contain vitamin K.
0B. subtilis has been completely removed.
0There is no damage due to stomach acid because of its acid-resistant capsule form.

・

Copyright(C)2004 Daiwa Pharmaceutical Co.,Ltd. All rights reserved. | HOME >